Vacinas

[kc_row use_container=”yes” force=”no” column_align=”middle” video_mute=”no” _id=”254204″][kc_column width=”12/12″ video_mute=”no” _id=”92622″][kc_column_text]

Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department-32302280.pdf

Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus_32209231.pdf

Considering BCG vaccination to reduce the impact of COVID-19_32359402.pdf

COVID-19, an emerging coronavirus infection_ advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics-32186952.pdf

Covid-19: What do we know so far about a vaccine?_32340998.pdf

Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 COVID-19_32238757

Development of an inactivated vaccine candidate for SARS-CoV-2.pdf

Development of epitope-based peptide vaccine against novel Coronavirus 2019 (SARS-COV-2) Immunoinformatics approach-32108359.pdf

El programa de inmunización en el contexto de la pandemia de COVID-19 Versión 2 24 de abril 2020_OPS.pdf

Human challenge studies to accelerate coronavirus vaccine licensure-32232474.pdf

Immune responses in COVID-19 and potential vaccines_Lessons learned from SARS and MERS epidemic-32105090.pdf

Immunoinformatics‐aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019‐nCoV_32022276.pdf

Microneedle array delivered recombinant coronavirus vaccines_ Immunogenicity and rapid translational development-32249203.pdf

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies-32106567.pdf

Progress and Prospects on Vaccine Development against SARS-CoV-2-32235387pdf

Rapid COVID-19 vaccine development-10.1126/science.abb8923.pdf

SARS-CoV-2 Vaccines_Status Report-32259480.pdf

The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines-32194995.pdf

The Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement-32305501pdf

The SARS-CoV-2 Vaccine Pipeline_an Overview-32219057..pdf

Tuberculosis (TB) y COVID-19 Lo que debes saber-OPS.pdf

Vaccine confidence in the time of COVID‑19-32318915.pdf

What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19-32295153.pdf

¿Qué sabemos de la vacuna frente a COVID-19?_Infografía_SEFAC.jpg

[/kc_column_text][/kc_column][/kc_row]